Shaperon PEG

Mitä Shaperon tekee? Shaperon Inc is a biotechnology company based in Seoul, South Korea, operating within the healthcare sector. The company focuses on the development of pharmaceutical products targeting conditions such as atopic dermatitis, septicemia, and Alzheimer's disease. Shaperon Inc. has a workforce of 40 full-time employees. The company completed its initial public offering (IPO) on October 19, 2022, and is listed under the ticker symbol 378800.KQ with ISIN KR7378800007. Its website is http://shaperon.com/. Shaperon Inc. is engaged in research, development, manufacturing, and commercialization of therapeutic solutions for pneumonia, Alzheimer's disease, and atopic conditions, among other medicines. The company's headquarters are located in Seoul, South Korea. Shaperon Inc. operates as a publicly traded entity following its IPO in 2022, with a focus on advancing treatments for complex medical conditions through biotechnology innovation. Shaperon on yksi Eurpooliin suosituimmista yhtiöistä.